Mammalian cellular systems are the foundation of modern human therapeutic development, yet their inherent heterogeneity and dynamic structural behaviors make them notoriously difficult to analyze accurately. Our Morphological and Phenotypic Analysis of Mammalian Systems service combines automated, high-content imaging (HCI) with deep learning and advanced computer vision to systematically decode mammalian cellular complexity at massive scale.
Instead of traditional, destructive assays that provide only a single, averaged endpoint readout, our AI-driven platform tracks thousands of individual cells in real time. We extract deep structural features and behavioral markers from complex cell models—such as human primary cells, stem cells, and 3D organoids—allowing pharmaceutical and biotechnology companies to precisely forecast drug efficacy, identify toxicity early, and map mechanisms of action with unprecedented confidence.
The neural network automatically isolates and tracks individual dynamic targets, generating a precise, fluid red tracking outline around the moving border of a cellular structure. The AI continuously calculates fine-scale phenotypic parameters, including membrane protrusion velocity, morphodynamic shifting, and target trajectory against the surrounding cellular matrix. By converting these microscopic visual movements into structured, mathematical data, the service provides biopharmaceutical R&D teams with an automated, non-destructive method to quantify real-time drug responses, cell migration patterns, and morphological deviations at single-cell resolution.